Auto-generated: July 17 2019 09:09 AM GMT

Star This?

Source: Expert Opin Pharmacother  |  Posted 8 years ago

Combination therapy with naltrexone and bupropion for obesity; Billes SK, Greenway FL; Expert Opinion on Pharmacotherapy (Jun 2011)

Introduction: Although pharmacological treatments for obesity represent only one option in managing obesity, they are a useful tool in an otherwise extremely limited armamentarium. Naltrexone/bupropion combination therapy was developed by using technological advances that have improved our understanding of how the brain regulates body weight. Areas covered: This review covers the development of naltrexone/bupropion combination therapy for obesity, as well as the published clinical trials on the safety and efficacy of the combination in overweight and obese humans. The effect of naltrexone/bupropion on food craving seems to be unique, and the implications of this finding for weight loss are discussed. Expert opinion: Safety and tolerability issues seem to be manageable and consistent with the documented effects of each component. Appropriate patient management should address the mild sympathomimetic effect of bupropion, although the FDA has required that a cardiovascular outcomes study be conducted preapproval to determine the effects of long-term use of naltrexone/bupropion in an overweight/obese population. When used in conjunction with diet and exercise, the naltrexone/bupropion combination may be a useful treatment option for obesity, especially for overweight and obese adults who report difficulty controlling eating behavior and their response to food cravings.

Star This?  Yes / No


Add walterdoege as a colleague

the clinical treatment of obesity and overweight patients is still a challenge and this drug combination trial is very interesting and useful in clinical practice.

Please sign in to post a comment
Sign InSign In
inst val